Physician profile
Wanida Walker
NPI 1205375045
$5,460.49
in general payments reported to CMS, 2019-2025
12 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $987 · 2023: $1,341 · 2024: $743 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,822.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,322.30 | 2021-2025 | Cabenuva, Apretude, Dovato |
| Gilead Sciences, INC. | $2,188.29 | 2021-2025 | Biktarvy, Descovy, Sunlenca |
| Theratechnologies INC. | $385.07 | 2021-2025 | Egrifta, Trogarzo |
| Janssen Scientific Affairs, LLC | $198.60 | 2021-2023 | Symtuza |
| Dynavax Technologies Corporation | $145.39 | 2022 | |
| Janssen Biotech, INC. | $106.87 | 2021-2023 | Symtuza |
| Amgen INC. | $21.64 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $21.44 | 2025 | Pifeltro |
| Qiagen, LLC | $20.21 | 2025 | |
| Exact Sciences Corporation | $19.37 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $18.88 | 2025 | Thinprep 2000 Processor, Aptima |
| Glaxosmithkline, LLC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanida Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.